HA
ARRY

Havens Advisors’s Array Biopharma Inc ARRY Stock Holding History

Havens Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-109,500
Closed -$5.07M – 34
2019
Q2 		$5.07M Buy
+109,500
New +$3.07M 3.57% 10

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Havens Advisors's ARRY Position: Q3 2019 in Review

Havens Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 109,500 shares — an estimated $5.07M sold.

Havens Advisors first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $5.07M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Havens Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Havens Advisors sold 109,500 Array Biopharma Inc shares in Q3 2019, an estimated $5.07M.
  • Havens Advisors first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Havens Advisors's Array Biopharma Inc position peaked at $5.07M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Havens Advisors's 13F filing for Q3 2019, filed 9 Oct 2019.